These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

399 related articles for article (PubMed ID: 10700188)

  • 1. Mutations truncating the EP300 acetylase in human cancers.
    Gayther SA; Batley SJ; Linger L; Bannister A; Thorpe K; Chin SF; Daigo Y; Russell P; Wilson A; Sowter HM; Delhanty JD; Ponder BA; Kouzarides T; Caldas C
    Nat Genet; 2000 Mar; 24(3):300-3. PubMed ID: 10700188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. No germline mutations in the histone acetyltransferase gene EP300 in BRCA1 and BRCA2 negative families with breast cancer and gastric, pancreatic, or colorectal cancer.
    Campbell IG; Choong D; Chenevix-Trench G;
    Breast Cancer Res; 2004; 6(4):R366-71. PubMed ID: 15217503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutation analysis of EP300 in colon, breast and ovarian carcinomas.
    Bryan EJ; Jokubaitis VJ; Chamberlain NL; Baxter SW; Dawson E; Choong DY; Campbell IG
    Int J Cancer; 2002 Nov; 102(2):137-41. PubMed ID: 12385008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Somatic mutations and genetic polymorphisms of the PPP1R3 gene in patients with several types of cancers.
    Takakura S; Kohno T; Shimizu K; Ohwada S; Okamoto A; Yokota J
    Oncogene; 2000 Feb; 19(6):836-40. PubMed ID: 10698503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutation analysis of hBUB1, human mitotic checkpoint gene in multiple carcinomas.
    Mimori K; Inoue H; Alder H; Ueo H; Tanaka Y; Mori M
    Oncol Rep; 2001; 8(1):39-42. PubMed ID: 11115566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutations of the E-cadherin gene in human gynecologic cancers.
    Risinger JI; Berchuck A; Kohler MF; Boyd J
    Nat Genet; 1994 May; 7(1):98-102. PubMed ID: 8075649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SMAD4 mutations in colorectal cancer probably occur before chromosomal instability, but after divergence of the microsatellite instability pathway.
    Woodford-Richens KL; Rowan AJ; Gorman P; Halford S; Bicknell DC; Wasan HS; Roylance RR; Bodmer WF; Tomlinson IP
    Proc Natl Acad Sci U S A; 2001 Aug; 98(17):9719-23. PubMed ID: 11481457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Compilation of somatic mutations of the CDKN2 gene in human cancers: non-random distribution of base substitutions.
    Pollock PM; Pearson JV; Hayward NK
    Genes Chromosomes Cancer; 1996 Feb; 15(2):77-88. PubMed ID: 8834170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered WAF1 genes do not play a role in abnormal cell cycle regulation in breast cancers lacking p53 mutations.
    McKenzie KE; Siva A; Maier S; Runnebaum IB; Seshadri R; Sukumar S
    Clin Cancer Res; 1997 Sep; 3(9):1669-73. PubMed ID: 9815858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutation analysis and characterization of ATR sequence variants in breast cancer cases from high-risk French Canadian breast/ovarian cancer families.
    Durocher F; Labrie Y; Soucy P; Sinilnikova O; Labuda D; Bessette P; Chiquette J; Laframboise R; Lépine J; Lespérance B; Ouellette G; Pichette R; Plante M; Tavtigian SV; Simard J
    BMC Cancer; 2006 Sep; 6():230. PubMed ID: 17010193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of mutations within ST7 gene in tumour-derived cell lines and primary epithelial tumours.
    Brown VL; Proby CM; Barnes DM; Kelsell DP
    Br J Cancer; 2002 Jul; 87(2):208-11. PubMed ID: 12107844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frequent down-regulation and lack of mutation of the KAI1 metastasis suppressor gene in epithelial ovarian carcinoma.
    Liu FS; Dong JT; Chen JT; Hsieh YT; Ho ES; Hung MJ
    Gynecol Oncol; 2000 Jul; 78(1):10-5. PubMed ID: 10873402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Establishment and characterization of human ovarian carcinoma cell lines.
    Yuan Y; Kim WH; Han HS; Lee JH; Park HS; Chung JK; Kang SB; Park JG
    Gynecol Oncol; 1997 Sep; 66(3):378-87. PubMed ID: 9299249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The BRCA2 is a histone acetyltransferase.
    Siddique H; Zou JP; Rao VN; Reddy ES
    Oncogene; 1998 Apr; 16(17):2283-5. PubMed ID: 9619837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deleterious CHEK2 1100delC and L303X mutants identified among 38 human breast cancer cell lines.
    Wasielewski M; Hanifi-Moghaddam P; Hollestelle A; Merajver SD; van den Ouweland A; Klijn JG; Ethier SP; Schutte M
    Breast Cancer Res Treat; 2009 Jan; 113(2):285-91. PubMed ID: 18297428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of the candidate 8p21 tumour suppressor, BNIP3L, in breast and ovarian cancer.
    Lai J; Flanagan J; Phillips WA; Chenevix-Trench G; Arnold J
    Br J Cancer; 2003 Jan; 88(2):270-6. PubMed ID: 12610513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic and epigenetic screening for gene alterations of the chromatin-remodeling factor, SMARCA4/BRG1, in lung tumors.
    Medina PP; Carretero J; Fraga MF; Esteller M; Sidransky D; Sanchez-Cespedes M
    Genes Chromosomes Cancer; 2004 Oct; 41(2):170-7. PubMed ID: 15287030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel somatic mutations in the BRCA1 gene in sporadic breast tumors.
    Janatova M; Zikan M; Dundr P; Matous B; Pohlreich P
    Hum Mutat; 2005 Mar; 25(3):319. PubMed ID: 15712267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutational analysis of the BRCA1-interacting genes ZNF350/ZBRK1 and BRIP1/BACH1 among BRCA1 and BRCA2-negative probands from breast-ovarian cancer families and among early-onset breast cancer cases and reference individuals.
    Rutter JL; Smith AM; Dávila MR; Sigurdson AJ; Giusti RM; Pineda MA; Doody MM; Tucker MA; Greene MH; Zhang J; Struewing JP
    Hum Mutat; 2003 Aug; 22(2):121-8. PubMed ID: 12872252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The 630-kb lung cancer homozygous deletion region on human chromosome 3p21.3: identification and evaluation of the resident candidate tumor suppressor genes. The International Lung Cancer Chromosome 3p21.3 Tumor Suppressor Gene Consortium.
    Lerman MI; Minna JD
    Cancer Res; 2000 Nov; 60(21):6116-33. PubMed ID: 11085536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.